These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 22610452)

  • 1. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial.
    Rosenfeld M; Ratjen F; Brumback L; Daniel S; Rowbotham R; McNamara S; Johnson R; Kronmal R; Davis SD;
    JAMA; 2012 Jun; 307(21):2269-77. PubMed ID: 22610452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial.
    Ratjen F; Davis SD; Stanojevic S; Kronmal RA; Hinckley Stukovsky KD; Jorgensen N; Rosenfeld M;
    Lancet Respir Med; 2019 Sep; 7(9):802-809. PubMed ID: 31178421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebulised hypertonic saline for cystic fibrosis.
    Wark P; McDonald VM
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001506. PubMed ID: 30260472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
    Saiman L; Anstead M; Mayer-Hamblett N; Lands LC; Kloster M; Hocevar-Trnka J; Goss CH; Rose LM; Burns JL; Marshall BC; Ratjen F;
    JAMA; 2010 May; 303(17):1707-15. PubMed ID: 20442386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.
    Elkins MR; Robinson M; Rose BR; Harbour C; Moriarty CP; Marks GB; Belousova EG; Xuan W; Bye PT;
    N Engl J Med; 2006 Jan; 354(3):229-40. PubMed ID: 16421364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of inhaled hypertonic saline on lung structure in children aged 3-6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trial.
    Tiddens HAWM; Chen Y; Andrinopoulou ER; Davis SD; Rosenfeld M; Ratjen F; Kronmal RA; Hinckley Stukovsky KD; Dasiewicz A; Stick SM;
    Lancet Respir Med; 2022 Jul; 10(7):669-678. PubMed ID: 35286860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid improves the tolerability of hypertonic saline in the chronic treatment of cystic fibrosis patients: a multicenter, randomized, controlled clinical trial.
    Ros M; Casciaro R; Lucca F; Troiani P; Salonini E; Favilli F; Quattrucci S; Sher D; Assael BM
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):133-7. PubMed ID: 23745525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS). A Randomized, Double-Blind, Controlled Study.
    Stahl M; Wielpütz MO; Ricklefs I; Dopfer C; Barth S; Schlegtendal A; Graeber SY; Sommerburg O; Diekmann G; Hüsing J; Koerner-Rettberg C; Nährlich L; Dittrich AM; Kopp MV; Mall MA
    Am J Respir Crit Care Med; 2019 May; 199(10):1238-1248. PubMed ID: 30409023
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled hypertonic saline in infants and toddlers with cystic fibrosis: short-term tolerability, adherence, and safety.
    Rosenfeld M; Davis S; Brumback L; Daniel S; Rowbotham R; Johnson R; McNamara S; Jensen R; Barlow C; Ratjen F
    Pediatr Pulmonol; 2011 Jul; 46(7):666-71. PubMed ID: 21365779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis.
    Subbarao P; Balkovec S; Solomon M; Ratjen F
    Pediatr Pulmonol; 2007 May; 42(5):471-6. PubMed ID: 17436328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of inhaled hypertonic (7%) saline on lung function test in preschool children with cystic fibrosis: results of a crossover, randomized clinical trial.
    Nenna R; Midulla F; Lambiase C; De Castro G; Zicari AM; Indinnimeo L; Cimino G; Troiani P; Quattrucci S; Tancredi G
    Ital J Pediatr; 2017 Jul; 43(1):60. PubMed ID: 28709466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
    Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF
    Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis.
    Dellon EP; Donaldson SH; Johnson R; Davis SD
    Pediatr Pulmonol; 2008 Nov; 43(11):1100-1106. PubMed ID: 18828160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline.
    Subbarao P; Stanojevic S; Brown M; Jensen R; Rosenfeld M; Davis S; Brumback L; Gustafsson P; Ratjen F
    Am J Respir Crit Care Med; 2013 Aug; 188(4):456-60. PubMed ID: 23742699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis.
    Dentice RL; Elkins MR; Middleton PG; Bishop JR; Wark PA; Dorahy DJ; Harmer CJ; Hu H; Bye PT
    Thorax; 2016 Feb; 71(2):141-7. PubMed ID: 26769016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot Randomized Controlled Trial Evaluating the Effect of Hypertonic Saline With and Without Hyaluronic Acid in Reducing Inflammation in Cystic Fibrosis.
    Brivio A; Conese M; Gambazza S; Biffi A; Tirelli AS; Russo M; Foà M; Colombo C
    J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):482-489. PubMed ID: 27149365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of hypertonic saline inhalation for cystic fibrosis.
    Elkins M; Dentice R
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD008816. PubMed ID: 32107770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of effects of 3 and 7% hypertonic saline nebulization on lung function in children with cystic fibrosis: a double-blind randomized, controlled trial.
    Gupta S; Ahmed F; Lodha R; Gupta YK; Kabra SK
    J Trop Pediatr; 2012 Oct; 58(5):375-81. PubMed ID: 22374985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.
    Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH
    Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.